NCT03082755View on ClinicalTrials.gov

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

August 31, 2022

Study Completion Date

March 31, 2023

Conditions
Alzheimer Disease
Interventions
DRUG

Gabapentin Enacarbil

1 to 2 GEn tablets (300 milligrams per tablet) will be administered once a day in the evening (about 5pm) for 8 weeks.

DRUG

Placebo Oral Tablet

1 to 2 Placebo Oral Tablets will be administered once a day in the evening (about 5pm) for 8 weeks.

Trial Locations (1)

78701

RECRUITING

The University of Texas at Austin, Austin

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Texas at Austin

OTHER